Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 240

1.

Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.

Burgoyne RW, Tan DH.

J Antimicrob Chemother. 2008 Mar;61(3):469-73. doi: 10.1093/jac/dkm499. Epub 2008 Jan 3. Review.

PMID:
18174196
2.

Predictors for lower quality of life in the HAART era among HIV-infected men.

Liu C, Johnson L, Ostrow D, Silvestre A, Visscher B, Jacobson LP.

J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):470-7.

PMID:
16810114
3.

Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy.

Venkat A, Piontkowsky DM, Cooney RR, Srivastava AK, Suares GA, Heidelberger CP.

Ann Emerg Med. 2008 Sep;52(3):274-85. doi: 10.1016/j.annemergmed.2008.01.324. Epub 2008 Mar 21. Review.

PMID:
18358567
4.

Quality of life and its correlates in HIV/AIDS male outpatients receiving highly active antiretroviral therapy in Taiwan.

Yen CF, Tsai JJ, Lu PL, Chen YH, Chen TC, Chen PP, Chen TP.

Psychiatry Clin Neurosci. 2004 Oct;58(5):501-6.

5.

Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.

Wyatt CM, Klotman PE.

Expert Opin Drug Saf. 2006 Mar;5(2):275-87. Review.

PMID:
16503748
6.

[An updated overview of HAART in HIV-infected adults].

Imamura A.

Nihon Rinsho. 2010 Mar;68(3):460-4. Review. Japanese.

PMID:
20229791
7.

Caring for HIV-infected patients in the ICU in the highly active antiretroviral therapy era.

Corona A, Raimondi F.

Curr HIV Res. 2009 Nov;7(6):569-79. Review.

PMID:
19929791
8.

Impact of depression on HIV outcomes in the HAART era.

Hartzell JD, Janke IE, Weintrob AC.

J Antimicrob Chemother. 2008 Aug;62(2):246-55. doi: 10.1093/jac/dkn193. Epub 2008 May 2. Review.

PMID:
18456650
9.

Critical care of HIV infected patients in the highly active antiretroviral therapy era.

Corona A, Raimondi F.

Minerva Anestesiol. 2007 Dec;73(12):635-45. Review.

10.

Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.

Madeddu G, Porqueddu EM, Cambosu F, Saba F, Fois AG, Pirina P, Mura MS.

Infection. 2008 Jun;36(3):231-6. doi: 10.1007/s15010-007-7162-0. Epub 2008 May 10.

PMID:
18463787
11.

HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors.

Jones R, Gazzard B.

Expert Rev Anti Infect Ther. 2006 Apr;4(2):303-12. Review.

PMID:
16597210
12.

Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.

Walenda C, Kouakoussui A, Rouet F, Wemin L, Anaky MF, Msellati P.

J Trop Pediatr. 2009 Jun;55(3):170-6. doi: 10.1093/tropej/fmn106. Epub 2008 Dec 9.

PMID:
19066169
13.

Gastrointestinal complications of HIV infection: changing priorities in the HAART era.

Wilcox CM, Saag MS.

Gut. 2008 Jun;57(6):861-70. doi: 10.1136/gut.2006.103432. Epub 2008 Jan 18. Review.

PMID:
18203808
14.

Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).

Kapogiannis BG, Soe MM, Nesheim SR, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M.

Pediatrics. 2008 May;121(5):e1229-39. doi: 10.1542/peds.2007-0871.

PMID:
18450865
15.

Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts.

Moodie EE, Pant Pai N, Klein MB.

PLoS One. 2009;4(2):e4517. doi: 10.1371/journal.pone.0004517. Epub 2009 Feb 18.

16.

Socio-economic impact of antiretroviral treatment in HIV patients. An economic review of cost savings after introduction of HAART.

Gonzalo T, García Goñi M, Muñoz-Fernández MA.

AIDS Rev. 2009 Apr-Jun;11(2):79-90. Review.

PMID:
19529748
17.

[AIDS--past, present and future].

Levy I, Shasha D, Grossman Z.

Harefuah. 2011 Mar;150(3):246-50, 304, 303. Hebrew.

PMID:
21574358
18.
19.

Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.

Corral I, Quereda C, Moreno A, Pérez-Elías MJ, Dronda F, Casado JL, Muriel A, Masjuán J, Alonso-de-Leciñana M, Moreno S.

Cerebrovasc Dis. 2009;27(6):559-63. doi: 10.1159/000214219. Epub 2009 Apr 24.

PMID:
19390181
20.

Unemployment as a risk factor for AIDS and death for HIV-infected patients in the era of highly active antiretroviral therapy.

Delpierre C, Cuzin L, Lauwers-Cances V, Datta GD, Berkman L, Lang T.

Sex Transm Infect. 2008 Jun;84(3):183-6. doi: 10.1136/sti.2007.027961. Epub 2008 Jan 11.

PMID:
18192292

Supplemental Content

Support Center